Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40David J Messenheimer, Shawn M Jensen, Michael E Afentoulis, et al.
Clinical & Translational Immunology|May 20, 2016
OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancerRyan Montler, R Bryan Bell, Colin Thalhofer, et al.
Oral Oncology|November 29, 2015
OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironmentR Bryan Bell, Rom S Leidner, Marka R Crittenden, et al.
Oncoimmunology|December 8, 2018
PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumabGabriele Madonna, Carmen Ballesteros-Merino, Zipei Feng, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Multispectral Fluorescence Imaging Allows for Distinctive Topographic Assessment and Subclassification of Tumor-Infiltrating and Surrounding Immune CellsClaudia Wickenhauser, Daniel Bethmann, Zipei Feng, et al.
Plos One|November 15, 2017
STING expression and response to treatment with STING ligands in premalignant and malignant diseaseJason R Baird, Zipei Feng, Hong D Xiao, et al.
The Laryngoscope|January 24, 2024
Recovery of Recurrent Laryngeal Nerve Function With Neoadjuvant Treatment: Neural CharacterizationMarika D Russell, Amr H Abdelhamid Ahmed, Zipei Feng, et al.
JCI Insight|July 21, 2017
Multiparametric immune profiling in HPV- oral squamous cell cancerZipei Feng, Daniel Bethmann, Matthias Kappler, et al.
Pageof 3